Odor identification and progression of Parkinsonian signs in older persons

Experimental Aging Research

Volumn 34, Issue 3, 2008, Pages 173-187

  Wilson, Robert S ^a   Arnold, Steven E ^b   Buchman, Aron S ^a   Tang, Yuxiao ^c   Bennett, David A ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; DISEASE COURSE; EDUCATION; FEMALE; FOLLOW UP; GAIT DISORDER; HUMAN; INSTRUMENTATION; MAJOR CLINICAL STUDY; MALE; ODOR; OLFACTORY DISCRIMINATION; PARKINSONISM; RATING SCALE; SCORING SYSTEM; SMELLING DISORDER;

AGE FACTORS; AGED; AGED, 80 AND OVER; DIFFERENTIAL THRESHOLD; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GAIT DISORDERS, NEUROLOGIC; HUMANS; HYPOKINESIA; MALE; MUSCLE RIGIDITY; ODORS; OLFACTION DISORDERS; PARKINSONIAN DISORDERS; PROGNOSIS; RISK FACTORS; TREMOR;

PARKINSONIA;

EID: 45849112207     PISSN: 0361073X     EISSN: 10964657     Source Type: Journal    
DOI: 10.1080/03610730802070001     Document Type: Article

References (47)

1. Bennett, D. A., Beckett, L. A., Murray, A. M., Shannon, K. M., Goetz, C. G., Pilgram, D. M., & Evans, D. A. (1996). Prevalence of parkinsonian signs and associated mortality in a community population of older people. New England Journal of Medicine, 334, 71-76.
2. Bennett, D. A., Schneider, J. A., Buchman, A. S., Mendes de Leon, C., Bienias, J. L., & Wilson, R. S. (2005). The rush memory and aging project: Study design and baseline characteristics of the study cohort. Neuropidemiology, 25, 169-175.
3. Bennett, D. A., Shannon, K. M., Beckett, L. A., Goetz, C. G., & Wilson, R. S. (1997). Metric properties of nurses' ratings of parkinsonian signs with a modified unified parkinson's disease rating scale. Neurology, 49, 1580-1587.
4. Braak, H., Del Tredici, K., Rub, V., de Vos, R. A. I., Steur, E. N. H. J., & Braak, E. (2003). Staging of brain pathology related to sporadic Parkinson's disease. Neurobiology of Aging, 24, 197-211.
5. Burns, J. M., Galvin, J. E., Roe, C. M., Morris, J. C., & McKeel, D. W. (2005). The pathology of the substantia nigra in Alzheimer's disease with extrapyramidal signs. Neurology, 64, 1397-1403.
6. Doty, R. L., Deems, D. A., & Stellar, S. (1988). Olfactory dysfunction in parkinsonism: A general deficit unrelated to neurologic signs, disease stage or disease duration. Neurology, 38, 1237-1244.
7. Doty, R. L., Frye, R. E., & Agarwal, U. (1989). Internal consistency reliability of the fractionated and whole University of Pennsylvania Smell Identification Test. Perception and Psychophysics, 45, 381-384.
8. Doty, R. L., Marcus, A., & Lee, W. W. (1996). Development of the 12-item cross-cultural smell identification test (CC-SIT). Laryngoscope, 106, 353-356.
9. Doty, R. L., Riklan, M., Deems, D. A., Reynolds, C., & Stellar, S. (1989). The olfactory and cognitive dificits of Parkinson's disease: Evidence for independence. Annals of Neurology, 25, 166-171.
10. Doty, R. L., Shaman, P., & Dann, M. (1984). Development of the University of Pennsylvania Smell Identification Test: A standardized microencapsulated test of olfactory function. Physiology & Behavior, 32, 489-502.
11. Doty, R. L., Stern, M. B., Pfeiffer, C., Gallomp, S. M., & Hortig, H. I. (1992). Bilateral olfactory function in early stage treated and untreated Parkinson's disease. Journal of Neurology, Neurosurgery, and Psychiatry, 55, 138-142.
12. Double, K. L., Rowe, D. B., Hayes, M., Chan, D. K., Blackie, J., Corbett, A., Joffe, R., Fung, V. S., Morris, J., & Halliday, G. M. (2003). Identifying the pattern of olfactory deficits in Parkinson's disease using the brief smell identification test. Archives of Neurology, 60, 545-549.
13. Fahn, S. & Elton, R. (1987). Unified Parkinson's disease rating scale. In S. Fahn, C. Marsden, & M. Goldstein (Eds.), Recent developments in Parkinson's disease (Vol. 12, pp. 153-163). Florham Park, NJ: MacMillan Healthcare Information.
14. Graves, A. B., Bowen, J. D., Rajaram, L., McCormick, W. C., McCurry, S. M., Schellenberg, G. D., & Larson, E. B. (1999). Impaired olfaction as a marker for cognitive decline: Interaction with apolipoprotein E e4 status. Neurology, 53, 1480-1487.
15. Hawkes, C. H., Shephard, B. C., Geddes, J. F., Body, G. D., & Martin, J. E. (1998). Olfactory disorder in motor neuron disease. Experimental Neurology, 150, 248-253.
16. Hoglinger, G. U., Rizk, P., Muriel, M. P., Duyckaerts, C., Oertel, W. H., Caille, I., & Hirsch, E. C. (2004). Dopamine depletion impairs precursor cell proliferation in Parkinson disease. Nature Neuroscience, 7, 726-735.
17. Katzenschlager, R., Zijlmans, J., Evans, A., Watt, H., & Lees, A. J. (2004). Olfactory function distinguishes vascular parkinsonism from Parkinson's disease. Journal of Neurology Neurosurgery and Psychiatry, 75, 1749-1752.
18. Kovacs, T., Cairns, N. J., & Lantos, P. L. (2001). Olfactory centres in Alzheimer's disease: Olfactory bulb is involved in early Braak's stages. Neuroreport, 12, 285-288.
19. Liang, K. Y. & Zeger, S. L. (1986). Longitudinal data analysis using generalized linear models. Biometrika, 73, 13-22.
20. Liu, Y., Stern, Y., Chun, M., Jacobs, D. M., Yau, P., & Goldman, J. E. (1997). Pathological correlates of extrapyramidal signs in Alzheimer's disease. Annals of Neurology, 41, 368-374.
21. Louis, E. D., Tang, M. X., & Mayeux, R. (2004). Parkinsonian signs in older people in a community-based study: Risk of incident dementia. Archives of Neurology, 61, 1273-1276.
22. Louis, E. D., Tang, M. X., Schupf, N., & Mayeux, R. (2005). Functional correlates and prevalence of mild parkinsonian signs in a community population of older persons. Archives of Neurology, 62, 297-302.
23. Marras, C., Goldman, S., Smith, A., Barney, P., Aston, D., Comyns, K., Kurell, M., Langston, J. W., Ross, G. W., & Tanner, C. M. (2005). Smell identification ability in twin pairs discordant for Parkinson's disease. Movement Disorders, 20, 687-693.
24. McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlin, E. (1984). Clinical diagnosis of Alzheimer's disease: Report of the NINCDS/ADRDA work group under the auspices of department of health and human services task force on Alzheimer's disease. Neurology, 34, 939-944.
25. McShane, R. J., Nagy, Z., Esiri, M. M., King, E., Joachim, C., Sullivan, N., & Smith, A. D. (2001). Anosmia in dementia is associated with Lewy bodies rather than Alzheimer's pathology. Journal of Neurology Neurosurgery and Psychiatry, 70, 739-743.
26. Mesholam, R. I., Moberg, P. J., Mahr, R. N., & Doty, R. L. (1998). Olfaction in neurodegenerative disease: A meta-analysis of olfactory functioning in Alzheimer's and Parkinson's diseases. Archives of Neurology, 55, 84-90.
27. Murphy, C., Schubert, C. R., Cruisckshanks, K. J., Klein, B. E., Klein, R., & Nondahl, D. M. (2002). Prevalence of olfactory impairment in older adults. Journal of the American Medical Association, 288, 2307-2312.
28. Nordin, S., Paulsen, J. S., & Murphy, C. (1995). Sensory-and memory-mediated olfactory dysfunction in Huntington's disease. Journal of the International Neuro-psychological Society, 1, 281-290.
29. Olichney, J. M., Murphy, C., Hofstetter, C. R., Foster, K., Hansen, L. A., Thal, L. J., & Katzman, R. (2005). Anosmia is very common in the Lewy body variant of Alzheimer's disease. Journal of Neurology Neurosurgery and Psychiatry, 76, 1342-1347.
30. Richards, M., Stern, Y., & Mayeux, R. (1993). Subtle extrapyramidal signs can predict the development of dementia in elderly individuals. Neurology, 43, 2184-2188.
31. SAS Institute Inc. (2004). SAS OnlineDoc ®9.1.3. Cary, NC: SAS Institute.
32. Serby, M., Larson, P., & Kalkstein, D. (1991). The nature and course of olfactory deficits in Alzheimer's disease. American Journal of Psychiatry, 418, 357-360.
33. Schneider, J. A., Li, J. L., Li, Y., Wilson, R. S., Kordower, J. H., & Bennett, D. A. (2006). Neurofibrillary tangles in the substantia nigra are related to gait impairment in older persons. Annals of Neurology, 59, 166-173.
34. Schneider, J. A., Wilson, R. S., Cochran, E. J., Bienias, J. L., Arnold, S. E., Evans, D. A., & Bennett, D. A. (2003). Relation of cerebral infarctions to dementia and cognitive function in older persons. Neurology, 60, 1082-1089.
35. 99mTc]TRODAT-1 SPECT imaging correlates with odor identification in early Parkinson''s disease. Neurology, 64, 1716-1720.
36. Sobel, N., Thomason, M. E., Stappen, I., Tanner, C. M., Tetrud, J. W., Bower, J. M., Sullivan, E. V., & Gabrieli, J. D. (2001). An impairment in sniffing contributes to the olfactory impairment in Parkinson's disease. Proceedings of the National Academy of Science of the United States of America, 98, 4154-4159.
37. Swan, G. E. & Carmelli, D. (2002). Impaired olfaction predicts cognitive decline in nondemented older adults. Neuroepidemiology, 21, 58-67.
38. Tsuboi, Y., Wszolek, Z. K, Graff-Radford, N. R., Cookson, N., & Dickson, D. W. (2003). Tau pathology in the olfactory bulb correlates with Braak stage, Lewy body pathology and apolipoprotein ε4. Neuropathology and Applied Neurbiology, 29, 503-510.
39. Wang, Q. S., Tian, L., Huang, Y. L., Qin, S., He, L. Q., & Zhou, J. N. (2002). Olfactory identification and apolipoprotein E e4 in mild cognitive impairment. Brain Research, 951, 77-81.
40. Wilson, R. S., Arnold, S. E., Schneider, J. A., Tang, Y., & Bennett, D. A. (2007). The relation of cerebral Alzheimer's disease pathology to odor identification in old age. Journal of Neurology Neurosurgery and Psychiatry, 78, 30-35.
41. Wilson, R. S., Arnold, S. E., Tang, Y., & Bennett, D. A. (2006). Odor identification and decline in different cognitive domains in old age. Neuroepidemiology, 26, 61-67.
42. Wilson, R. S., Barnes L. L., Krueger, K. R., Hoganson, G., Bienias, J. L., & Bennett, D. A. (2005). Early and late life cognitive activity and cognitive systems in old age. Journal of the International Neuropsychology Society, 11, 400-407.
43. Wilson, R. S., Bennett, D. A., Gilley, D. W., Beckett, L. A., Schneider, J. A., & Evans, D. A. (2000). Progression of parkinsonism and loss of cognitive function in Alzheimer's disease. Archives of Neurology, 57, 855-860.
44. Wilson, R. S., Mendes de Leon, C. F., Barnes, L. L., Schneider, J. A., Bienias, J. L., Evans, D. A., & Bennett, D. A. (2002). Participation in cognitively stimulating activities and risk of incident Alzheimer's disease. Journal of the American Medical Association, 287, 742-748.
45. Wilson, R. S., Schneider, J. A., Beckett, L. A., Evans, D. A., & Bennett, D. A. (2002). Progression of gait disorder and rigidity and risk of death in older persons. Neurology, 58, 1815-1819.
46. Wilson, R. S., Schneider, J. A., Bienias, J. L., Evans, D. A., & Bennett, D. A. (2003). Parkinsonianlike signs and risk of incident Alzheimer's disease in older persons. Archives of Neurology, 60, 539-544.
47. Winikates, J. & Jankovic, J. (1999). Clinical correlates of vascular parkinsonism. Archives of Neurology, 56, 98-102.